Compounds > 3,4-dihydroxyphenylacetic acid

3,4-dihydroxyphenylacetic acid and g(m1) ganglioside

3,4-dihydroxyphenylacetic acid has been researched along with g(m1) ganglioside in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (13.64)	18.7374
1990's	16 (72.73)	18.2507
2000's	1 (4.55)	29.6817
2010's	2 (9.09)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DiStefano, L; Pope, A; Schneider, JS; Simpson, K; Smith, MG; Taggart, J	1
Schneider, JS	2
Hadjiconstantinou, M; Neff, NH; Yates, AJ	1
de Montis, G; Rossetti, ZL; Stefanini, E; Vaccari, A	1
Albert, ML; Davoudi, H; Durso, R; Fazzini, E; Szabo, GK	1
Hadjiconstantinou, M; Neff, NH	2
Hadjiconstantinou, M; Mariani, AP; Neff, NH	1
Ali, SF	1
Distefano, L; Schneider, JS	4
Iacovitti, L; Schneider, JS; Stull, ND	1
Berrian, J; DiStefano, L; Schneider, JS; Smith, MG	1
Dalia, A; Hadjiconstantinou, M; Neff, NH	1
Koga, T; Lazzaro, A; Manev, H; Schiavo, N; Seren, MS; Zanoni, R	1
Duchemin, AM; Goettl, VM; Hadjiconstantinou, M; Neff, NH; Wemlinger, TA	1
Fong, TG; Goettl, VM; Hadjiconstantinou, M; Neff, NH; Wemlinger, TA	1
Kulkarni, N; Ledeen, RW; Lu, ZH; Wu, G	1
Duchemin, AM; Hadjiconstantinou, M; Neff, NH; Newburn, EN	1

Other Studies

22 other study(ies) available for 3,4-dihydroxyphenylacetic acid and g(m1) ganglioside

Article	Year
Recovery from experimental parkinsonism in primates with GM1 ganglioside treatment. Science (New York, N.Y.), 1992, May-08, Volume: 256, Issue:5058 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Immunohistochemistry; Macaca fascicularis; Motor Activity; Parkinson Disease, Secondary; Putamen; Reference Values; Saimiri; Tyrosine 3-Monooxygenase	1992
Effects of age on GM1 ganglioside-induced recovery of concentrations of dopamine in the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Neuropharmacology, 1992, Volume: 31, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Male; Mice; Mice, Inbred C57BL	1992
MPTP-induced parkinsonism: acceleration of biochemical and behavioral recovery by GM1 ganglioside treatment. Journal of neuroscience research, 1992, Volume: 31, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cats; Caudate Nucleus; Dopamine; Female; G(M1) Ganglioside; Homovanillic Acid; Male; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary	1992
Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside. Journal of neurochemistry, 1990, Volume: 55, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Animals, Newborn; Brain; Choline; Corpus Striatum; Dopamine; Frontal Lobe; G(M1) Ganglioside; Hippocampus; Hydroxyindoleacetic Acid; Hypoxia; Neurons; Neurotransmitter Agents; Organ Size; Rats; Serotonin	1990
Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside. Neuropharmacology, 1990, Volume: 29, Issue:12 Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Animals, Newborn; Corpus Striatum; Dopamine; Female; G(M1) Ganglioside; Homovanillic Acid; Hypothyroidism; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Synaptosomes; Thyroid Gland; Tyramine	1990
GM1 gangliosides alter acute MPTP-induced behavioral and neurochemical toxicity in mice. Journal of the neurological sciences, 1990, Volume: 99, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Corpus Striatum; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Male; Mice; Mice, Inbred Strains; Movement; Parkinson Disease; Parkinson Disease, Secondary	1990
Treatment with GM1 ganglioside increases rat spinal cord indole content. Brain research, 1986, Feb-26, Volume: 366, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Dopamine; G(M1) Ganglioside; Hydroxyindoleacetic Acid; Indoles; Male; Norepinephrine; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord	1986
GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study. Brain research, 1989, Apr-10, Volume: 484, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Immunohistochemistry; Male; Mice; Parkinson Disease, Secondary; Pyridines; Substantia Nigra; Tyrosine 3-Monooxygenase	1989
Treatment with GM1 ganglioside restores striatal dopamine in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. Journal of neurochemistry, 1988, Volume: 51, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Male; Mice; Pyridines	1988
Lack of mitigation of methamphetamine-induced neurotoxicity by ganglioside GM1 or vitamin E. Annals of the New York Academy of Sciences, 1995, Sep-15, Volume: 765 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Hydroxyindoleacetic Acid; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Reactive Oxygen Species; Serotonin; Vitamin E	1995
Response of the damaged dopamine system to GM1 and semisynthetic gangliosides: effects of dose and extent of lesion. Neuropharmacology, 1995, Volume: 34, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; G(M1) Ganglioside; Gangliosides; Mice; Mice, Inbred C57BL; Sphingosine	1995
Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments. Brain research, 1995, Mar-20, Volume: 674, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Epidermal Growth Factor; Fibroblast Growth Factor 2; G(M1) Ganglioside; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neostriatum; Tyrosine 3-Monooxygenase	1995
GM1 ganglioside partially rescues cultured dopaminergic neurons from MPP(+)-induced damage: dependence on initial damage and time of treatment. Brain research, 1994, Mar-21, Volume: 640, Issue:1-2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cells, Cultured; Chromatography, High Pressure Liquid; Dopamine; G(M1) Ganglioside; Immunohistochemistry; Neurons; Pyridinium Compounds; Rats; Tyrosine 3-Monooxygenase	1994
GM1 ganglioside treatment partially reverses the nigrostriatal dopamine defect in the weaver mutant mouse. Brain research, 1994, Feb-14, Volume: 636, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dopamine Agents; Female; G(M1) Ganglioside; Heterozygote; Male; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Neurologic Mutants; Neostriatum; Neural Pathways; Neurons; Substantia Nigra; Tyrosine 3-Monooxygenase	1994
GM1 ganglioside improves dopaminergic markers of rat mesencephalic cultures treated with MPP+. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1993, Volume: 13, Issue:7 Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Cells, Cultured; Cytarabine; Dopamine; G(M1) Ganglioside; Gestational Age; Immunohistochemistry; Kinetics; Mesencephalon; Neuroglia; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase	1993
LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment. Neuroreport, 1993, Nov-18, Volume: 5, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Drug Resistance; G(M1) Ganglioside; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Parkinson Disease, Secondary; Sphingosine	1993
Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism. Neurology, 1994, Volume: 44, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Administration, Oral; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Homovanillic Acid; Male; Mice; Mice, Inbred C57BL; Osmolar Concentration; Parkinson Disease, Secondary; Sphingolipids; Sphingosine	1994
GM1 reduces infarct volume after focal cerebral ischemia. Experimental neurology, 1994, Volume: 125, Issue:2 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Edema; Brain Ischemia; Caudate Nucleus; Cerebral Infarction; Choline O-Acetyltransferase; Dopamine; G(M1) Ganglioside; Isoquinolines; Male; Putamen; Rats; Rats, Sprague-Dawley	1994
GM1 ganglioside restores dopaminergic neurochemical and morphological markers in aged rats. Neuroscience, 1999, Volume: 92, Issue:3 Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Corpus Striatum; Dopamine; G(M1) Ganglioside; Male; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tissue Distribution; Tyrosine 3-Monooxygenase	1999
Retinal cholinergic and dopaminergic deficits of aged rats are improved following treatment with GM1 ganglioside. Brain research, 2000, Sep-15, Volume: 877, Issue:1 Topics: 3,4-Dihydroxyphenylacetic Acid; Age Factors; Animals; Aromatic-L-Amino-Acid Decarboxylases; Biomarkers; Carrier Proteins; Choline O-Acetyltransferase; Dopamine; G(M1) Ganglioside; Hemicholinium 3; Male; Membrane Transport Proteins; Rats; Rats, Sprague-Dawley; Retina; Tyrosine 3-Monooxygenase	2000
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans. Journal of neuroscience research, 2012, Volume: 90, Issue:10 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aged, 80 and over; Aging; Animals; Antiparkinson Agents; Blotting, Western; Cell Count; Dopamine; Dopaminergic Neurons; Female; G(M1) Ganglioside; Gangliosides; Humans; Immunohistochemistry; Levodopa; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Acetylgalactosaminyltransferases; Parkinson Disease; Polypeptide N-acetylgalactosaminyltransferase; Synucleins; Tyrosine 3-Monooxygenase	2012
GM1 ganglioside enhances Ret signaling in striatum. Journal of neurochemistry, 2014, Volume: 130, Issue:4 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Dopamine; G(M1) Ganglioside; Glial Cell Line-Derived Neurotrophic Factor; Glial Cell Line-Derived Neurotrophic Factor Receptors; Immunoprecipitation; In Vitro Techniques; Male; Mice; Neostriatum; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-ret; Signal Transduction; src-Family Kinases	2014